Precision medicines need precision insights. Gain the insights you need to compete differently and fill the gaps left by traditional data analysis. ClosedLoop’s predictive analytics for Life Science commercial teams can deliver precision, speed, and productivity and help you optimize your go-to-market strategy and maximize commercial performance.
Precision medicines need precision insights. Gain the insights you need to compete differently and fill the gaps left by traditional data analysis. ClosedLoop’s predictive analytics for Life Science commercial teams can deliver precision, speed, and productivity.
ClosedLoop generates explainable predictions using
thousands of auto-generated, clinically relevant contributing factors
Leverage AI to power your launch, refine your market, and kickstart commercial performance.
Create targeted content based on the specific needs of key sub-populations and patient cohorts.
Keep your finger on the pulse of your product and its impact.
Business development and commercial teams need precise answers to gauge the value of
potential partnership deals and explore new market opportunities.
ClosedLoop is an exciting and important partner in our strategy to develop timely predictive insights through operationalized AI solutions that will drive member engagement and better health outcomes.
Our partnership with ClosedLoop adds the depth of AI to more accurately identify those patients who are most likely to benefit from our primary care interventions as well to evaluate these interventions and make more relevant and timely modifications to improve their effectiveness.
We are extremely impressed with the predictive modeling capabilities the ClosedLoop platform has delivered. The ClosedLoop team has exceeded all defined goals and benchmarks set to date and we anticipate a substantial return on our investment as these predictions are operationally deployed.
We’re able to store and operationalize analytics directly from ClosedLoop. That’s driving real value—it’s accelerated the implementation of key insights into clinical workflows and it allows us to more easily account for all of the different factors that influence intervention decisions.
At SWHR, our patient-centered network is committed to innovative care models that are value-based, high-quality, and data-driven. Because of our partnership with ClosedLoop, we’re better able to identify and act on the most impactful opportunities for our physician partners to improve patient results and reduce unnecessary costs.
We compared the ClosedLoop predicted spend to the spend predicted by a leading rules-based risk prediction engine and found that 75% of the time ClosedLoop was closer, and in most cases significantly closer, to the actual spend.
Using predictive analytics to supplement clinician-driven referrals has helped me identify more patients more quickly for complex case management. I have greater assurance knowing this tool is helping me find patients most in need of my care.
ClosedLoop stood out from other AI firms in that they offered not only a usable, flexible analytics platform but extensive healthcare expertise.